Dev

STUDY OF THE EXOSOMAL MICRORNA EXPRESSION PROFILE IN BIOFLUIDS FOR THE IDENTIFICATION OF DIAGNOSTIC USE BIOMARKERS IN FRONTOTEMPORAL DEMENTIA Investments < €500k Spain 2016    

CEREBRAL STRUCTURE AND METABOLISM IN ALZHEIMER’S DISEASE PRECLINICA. INTERACTIONS BETWEEN “NEW AND OLD” BIOMARCADORES. Investments < €500k Spain 2016    

ALZHEIMER’S DISEASE AND DOWN SYNDROME. MULTIMODAL STUDIES OF CLEAR LIQUID, MAGNETIC RESONANCE AND PET OF AMYLOID. Investments < €500k Spain 2016    

ANATOMICAL-FUNCTIONAL CORRELATES OF DISORDERS OF THE CONTROL OF IMPULSES AND APATIA IN PARKINSON’S DISEASE Investments < €500k Spain 2016    

PREDICTIVE STUDY OF THE DEVELOPMENT OF SMALL BRAIN DISEASE IN HIGH RISK PATIENTS. Investments < €500k Spain 2016    

NEURONAL PLASTICITY IN LEKODOPA-INDUCED DISEASES IN PARKINSON’S DISEASE Investments < €500k Spain 2016    

STUDY OF THE GENES INVOLVED IN PARKINSON’S DISEASE BY SEQUENCING THE EXOMA Investments < €500k Spain 2016    

MONITORING THE MOBILITY OF PARKINSON ILLNESSES WITH THERAPEUTIC PURPOSES – 3 (MOMOPA-3) Investments < €500k Spain 2016    

CLINICAL AND RADIOLOGICAL QUANTITATIVE EVALUATION IN PATIENTS PMM2-CDG THROUGH A NATIONAL NETWORK OF PROFESSIONALS. Investments < €500k Spain 2016    

GENETICALLY DETERMINED PARKINSON DISEASE NEUROIMAGEN MARKERS Investments < €500k Spain 2016